申请人:Tsantrizos Youla S.
公开号:US20100168098A1
公开(公告)日:2010-07-01
The present invention relates to compounds represented by formula (I) wherein A, B, D, E, R
2
, R
3
, R
4
, R
5
, R
6
, R
9
, a, b, d and e are as defined herein, their salt or ester and pharmaceutical compositions thereof useful in the treatment of hepatitis C viral (HCV) infection. Said compounds were found to have inhibitory activity against HCV polymerase, especially as inhibitors of HCV NS5B polymerase